TRYPANOSOMA CRUZI - ANVISA Registration 81816720082

Access comprehensive regulatory information for TRYPANOSOMA CRUZI in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720082 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Feb 17, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, WIENER LABORATORIOS S.A.I.C., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.